Open AccessCitation classics in central nervous system inflammatory demyelinating disease
Author(s) -
Kim JeeEun,
Park Kang M.,
Kim Yerim,
Yoon Dae Y.,
Bae Jong S.
Publication year - 2017
Publication title -
brain and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.915
H-Index - 41
ISSN - 2162-3279
DOI - 10.1002/brb3.700
Subject(s) - citation , multiple sclerosis , neuromyelitis optica , medicine , demyelinating disease , optic neuritis , web of science , experimental autoimmune encephalomyelitis , disease , library science , immunology , pathology , computer science , meta analysis
Objectives To identify and analyze the characteristics of the most influential articles about central nervous system ( CNS ) inflammatory demyelinating disease. Materials and Methods The Institute for Scientific Information (ISI) Web of Science database and the 2014 Journal Citation Reports Science Edition were used to retrieve the top 100 cited articles on CNS inflammatory demyelinating disease. The citation numbers, journals, years of publication, authorships, article types, subjects and main issues were analyzed. For neuromyelitis optica (NMO), articles that were cited more than 100 times were regarded as a citation classic and described separately. Results The top 100 cited articles were published between 1972 and 2011 in 13 journals. The highest number of articles ( n = 24) was published in Brain, followed by The New England Journal of Medicine ( n = 21). The average number of citations was 664 (range 330–3,897), and 64% of the articles were from the United States and the United Kingdom. The majority of the top 100 cited articles were related to multiple sclerosis ( n = 87), and only a few articles reported on other topics such as NMO ( n = 9), acute disseminated encephalomyelitis ( n = 2) and optic neuritis ( n = 2). Among the top 100 cited articles, 77% were original articles. Forty‐one citation classics were found for NMO. Conclusions Our study provides a historical perspective on the research progress on CNS inflammatory demyelinating disease and may serve as a guide for important advances and trends in the field for associated researchers.